NOTICE
ANSM - Updated: 09/03/2017
Name of the drug
MERCUR SOL Complex n ° 39, sublingual tablet
framed
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
You should always take this medicine exactly as described in this leaflet or by your doctor or pharmacist.
· Keep this leaflet. You might need to read it again.
· Talk to your pharmacist for any advice or information.
· If you get any side effects, talk to your doctor or pharmacist. This also applies to any undesirable effect that is not mentioned in this leaflet. See section 4.
· You should talk to your doctor if you do not feel better or if you feel worse after 5 days.
Do not let this medicine within the reach of children.
What does this booklet contain ?
1. What is MERCUR SOL COMPLEX No. 39, sublingual tablet and when is it used?
2. What information do you need to know before taking MERCUR SOL COMPLEX No. 39, sublingual tablet?
3. How to take MERCUR SOL COMPLEX No. 39, sublingual tablet?
4. What are the possible side effects?
5. How to store MERCUR SOL COMPLEX No. 39, sublingual tablet?
6. Contents of the package and other information.
1. WHAT IS MERCUR SOL COMPLEX No. 39, sublingual tablet AND WHAT IT IS USED FOR?
Pharmacotherapeutic group - Homeopathic medicine
MERCUR SOL COMPLEX No. 39, sublingual tablet is a homeopathic medicine traditionally used in rhinopharyngitis, tracheitis or bronchitis.
2. WHAT YOU SHOULD KNOW BEFORE TAKING MERCUR SOL COMPLEXE No. 39, sublingual tablet?
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Do not take MERCUR SOL COMPLEX No. 39, sublingual tablet:
· In children under 6 years of age, due to the risk of miscarriage related to the pharmaceutical form.
· If you are allergic (hypersensitive) to the active substances or to any of the other ingredients of this medicine, listed in section 6.
Warnings and precautions
Talk to your doctor or pharmacist before taking MERCUR SOL COMPLEX No. 39, sublingual tablet .
This medicine contains lactose. Its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency or glucose or galactose malabsorption syndrome (rare hereditary diseases).
children
Not applicable.
Other medicines and MERCUR SOL COMPLEX No. 39, sublingual tablet
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
MERCUR SOL COMPLEX # 39, sublingual tablet with food and drinks
This medication should preferably be taken away from meals.
Pregnancy and breast feeding
In the absence of experimental and clinical data, and as a precaution, the use of this drug should be avoided during pregnancy and lactation.
Sport
Not applicable.
Driving and using machines
Not applicable.
MERCUR SOL COMPLEX No. 39, sublingual tablet contains lactose.
3. HOW TO TAKE MERCUR SOL COMPLEX No. 39, sublingual tablet?
Always take this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist. Check with your doctor or pharmacist if in doubt.
Dosage
Adults: 2 tablets 2-3 times daily
Children over 6 years old: 1 tablet 2 to 3 times a day
Maximum duration of treatment: 5 days.
Administration mode
Chew and let the tablet melt under the tongue, preferably outside of meals.
Sublingual route.
If you take more than MERCUR SOL COMPLEX No. 39, sublingual tablet that you should have:
Immediately consult your doctor or pharmacist.
If you forget to take MERCUR SOL COMPLEX # 39, sublingual tablet:
Do not take a double dose to make up for the dose you forgot to take.
If you stop taking MERCUR SOL COMPLEX No. 39, sublingual tablet:
Not applicable.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This also applies to any undesirable effect that is not mentioned in this leaflet. You can also report side effects directly via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr
By reporting side effects, you can help provide more information about the safety of the medicine.
5. HOW TO STORE MERCUR SOL COMPLEX No. 39, sublingual tablet?
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister or package . The expiry date refers to the last day of this month.
No special storage conditions.
Do not use this medicine if you notice any visible signs of deterioration.
Do not dispose of any medication in the sewage system or in the household garbage. Ask your pharmacist to eliminate medications that you no longer use. These measures will help protect the environment.
6. CONTENTS OF PACKAGING AND OTHER INFORMATION
What MERCUR SOL COMPLEX No. 39, sublingual tablet contains
· The active substances are:
Mercurius solubilis 8 DH .............................................. .................................................. .... 40 mg
Aurum muriaticum natronatum 8 DH ............................................. ...................................... 40 mg
Kalium iodatum 4 DH .............................................. .................................................. ......... 40 mg
Natrum nitricum 3 DH .............................................. .................................................. ........ 40 mg
Natrum sulfuricum 2 DH .............................................. .................................................. ..... 40 mg
Kalium phosphoricum 3 DH .............................................. .................................................. 40 mg
for a 250 mg tablet
· The other ingredients are: lactose, rice starch, magnesium stearate.
What MERCUR SOL COMPLEXE No. 39 sublingual tablet looks like and contents of the pack
MERCUR SOL Complex No. 39, sublingual tablet is a 250 mg tablet, packaged in blister packs.
Box of 3 packs of 20 tablets.
Marketing Authorization Holder
LEHNING LABORATORIES
3 RUE DU PETIT MARAIS
57640 SAINTE-BARBE
LA FRANCE
Operator of the marketing authorization
LEHNING LABORATORIES
3 RUE DU PETIT MARAIS
57640 SAINTE-BARBE
LA FRANCE
Maker
LEHNING LABORATORIES
3 RUE DU PETIT MARAIS
57640 SAINTE-BARBE
LA FRANCE
Names of the drug in the member states of the European Economic Area
Not applicable.
The last date this leaflet was revised is:
To be completed later by the holder.
Other
Detailed information on this medicine is available on the ANSM website (France).